Cardiovascular and Metabolic Effects of Modulating Circulating Ketone Bodies With 1,3‐Butanediol in Patients With Heart Failure With Reduced Ejection Fraction
Journal of the American Heart Association · 07.01.2025 · 14 (1)
DOI: 10.1161/jaha.124.038461 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 07.01.2025. Verfasst von Halvor Guldbrandsen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Aarhus University Hospital Aarhus Denmark. Hauptthemen laut MEDLINE: Heart Failure, Butylene Glycols, Stroke Volume, Cross-Over Studies. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background Oral treatment with the exogenous ketone body 3‐hydroxybutyrate improves cardiac function in patients with heart failure with reduced ejection fraction, but ketosis is limited to 3 to 4 hours. Treatment with (R)‐1,3‐butanediol (BD) provides prolonged ketosis in healthy controls, but the hemodynamic and metabolic profile is unexplored in patients with heart failure with reduced ejection fraction. Methods and Results This was a randomized, single‐blind, placebo‐controlled, crossover study. Transthoracic echocardiography and venous blood samples were performed at baseline and hourly for 6 hours after an oral dose of BD (0.5 g/kg) or taste‐matched placebo. The primary end point was the average between‐treatment difference in cardiac output during the 6‐hour period after intake. Secondary end points were stroke volume, heart rate, left ventricular ejection fraction, circulating 3‐hydroxybutyrate, and free fatty acids. Twelve patients with heart failure with reduced ejection fraction were included. BD treatment provided significant increase in circulating 3‐hydroxybutyrate by 1400 μmol/L (95% CI, 1262–1538 μmol/L, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology Aarhus University Hospital Aarhus Denmark.
- Department of Cardiology Viborg Regional Hospital Viborg Denmark.
- Department of Clinical Medicine, Faculty of Health Aarhus University Aarhus Denmark.
- Department of Cardiology Gødstrup Hospital Herning Denmark.
ORCID-Profile: Halvor Guldbrandsen, Nigopan Gopalasingam, Oskar Kjærgaard Hørsdal, Roni Nielsen, Henrik Wiggers, Kristoffer Berg-Hansen
Zitieren
APA
Guldbrandsen, H., Gopalasingam, N., Christensen, K. H., Hørsdal, O. K., Nielsen, R., Wiggers, H., & Berg-Hansen, K. (2025). Cardiovascular and Metabolic Effects of Modulating Circulating Ketone Bodies With 1,3‐Butanediol in Patients With Heart Failure With Reduced Ejection Fraction. Journal of the American Heart Association, 14(1). https://doi.org/10.1161/jaha.124.038461
Vancouver
Guldbrandsen H, Gopalasingam N, Christensen KH, Hørsdal OK, Nielsen R, Wiggers H, et al. Cardiovascular and Metabolic Effects of Modulating Circulating Ketone Bodies With 1,3‐Butanediol in Patients With Heart Failure With Reduced Ejection Fraction. Journal of the American Heart Association. 2025;14(1). doi:10.1161/jaha.124.038461
BibTeX
@article{Guldbrandsen2025,
author = {Guldbrandsen, Halvor and Gopalasingam, Nigopan and Christensen, Kristian Hylleberg and Hørsdal, Oskar Kjærgaard and Nielsen, Roni and Wiggers, Henrik and Berg-Hansen, Kristoffer},
title = {Cardiovascular and Metabolic Effects of Modulating Circulating Ketone Bodies With 1,3‐Butanediol in Patients With Heart Failure With Reduced Ejection Fraction},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {1},
doi = {10.1161/jaha.124.038461}
}
EUVIMED